About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » Follicular Lymphoma

Follicular Lymphoma News, Research and Latest Updates

Keep abreast with the latest news related to Follicular Lymphoma there are 13 news items on Follicular Lymphoma that covers updates, breakthroughs and in-depth reports.

We provide you with a free downloadable secure widget for your website to carry news related to Follicular Lymphoma.

Follicular Lymphoma

Follicular lymphoma is a slow growing cancer of the lymph nodes. It is the most common form of slow growing B-cell non-Hodgkin’s lymphoma.

Age not Linked to Survival in Non-Hodgkin Lymphoma Patients

Age not Linked to Survival in Non-Hodgkin Lymphoma Patients

Age is not a limiting factor for Hematopoietic Cell Transplantation (HCT) in patients with non-Hodgkin lymphoma (NHL), finds a retrospective study.

New Gene Expression Assay Aids Non-Hodgkin Lymphoma Treatment

New Gene Expression Assay Aids Non-Hodgkin Lymphoma Treatment

Better subtyping of diffuse large B-cell lymphomas can enhance diagnosis and guide treatment, reports The Journal of Molecular Diagnostics.

Copanlisib FDA-approved for Relapsed Follicular Lymphoma in Adults

Copanlisib FDA-approved for Relapsed Follicular Lymphoma in Adults

Copanlisib, a drug that has recently been FDA approved for the treatment of follicular cancer, appears to be a good option to prevent relapses.

Advertisement

Follicular Lymphoma : Sestrin1 Gene Link Detected

Follicular Lymphoma : Sestrin1 Gene Link Detected

Sestrin1 gene loss of function or down regulation leads to an increased risk of follicular lymphoma.

B-Cell Non-Hodgkin Lymphoma Risk in Middle Eastern Populations

B-Cell Non-Hodgkin Lymphoma Risk in Middle Eastern Populations

Very few epidemiological studies have been conducted on B-cell non-Hodgkin lymphoma (B-NHL) in Middle Eastern populations.

Follicular Lymphoma Patients May Benefit From Combination Therapy

Follicular Lymphoma Patients May Benefit From Combination Therapy

A high risk group of patients with follicular lymphoma may benefit from a novel drug combination, a new study has found

Advertisement

Non-Hodgkin Lymphoma Gets Easier to Treat With a New Drug

Non-Hodgkin Lymphoma Gets Easier to Treat With a New Drug

With repeated relapse among patients and the disease becoming resistant to therapy, indolent and slow-growing non-Hodgkin lymphoma is now getting difficult to deal with

Drug Combination Leads to Complete Remission in Half of Patients With Follicular Lymphoma

Drug Combination Leads to Complete Remission in Half of Patients With Follicular Lymphoma

A combination of two drugs, one which attacks the tumor cells directly while the other treats the immune system by taking the brakes off T cell response, has managed to trigger complete remission.

Overall Survival in Follicular Lymphoma Patients Not Improved by Autologous Stem Cell Transplantation

Overall Survival in Follicular Lymphoma Patients Not Improved by Autologous Stem Cell Transplantation

Formerly untreated patients with advanced follicular lymphoma (FL) show no improvement in the overall survival with High-dose chemotherapy.

Advertisement

Non-Hodgkin Lymphoma may be Triggered by Obesity and Dietary Choices

Non-Hodgkin Lymphoma may be Triggered by Obesity and Dietary Choices

Research indicates that body weight and dietary choices in young adulthood can trigger non-Hodgkin lymphoma in later life.

Download Follicular Lymphoma News Widget

Recommended Reading

Chlorambucil

This medication is a cytotoxic chemotherapy drug, prescribed for chronic lymphocytic leukemia, non-Hodgkin's lymphoma, Hodgkin's disease and ...

Tositumomab and Iodine 1131 Tositumomab

Tositumomab and Iodine 1131 Tositumomab

This medication is a monoclonal antibody, prescribed for non-Hodgkin ...

Rituximab

This medication is a monoclol antibody, prescribed for certain types of cancer such as lymphomas, leukemia, transplant rejection and some autoimmune ...

Types of Non-Hodgkins Lymphoma (NHL)

Types of Non-Hodgkins Lymphoma (NHL)

Non-Hodgkins lymphomas are broadly classified depending on the type of lymphocyte affected and on the rate of its progress.

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional